Updated Jul 16, 2026 · Last SEC filing 2026-07-16
Traws Pharma, Inc. (TRAW) has filed 10 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-16. 7 Form 8-K material event filings were reported by TRAW in the last 90 days. InsiderAlpha tracks every TRAW SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001130598 |
| Form 4 filings (90d) | 10 |
|---|---|
| Form 8-K filings (90d) | 7 |
| Latest Form 4 filing | 2026-07-16 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% Owner | P — Open-market purchase | 597.7K | $1.67 | $998K | SEC | |
| Leaman John Harold | Insider | A — Grant or award | 4.1K | $0.00 | — | SEC | |
| Clarke Trafford | Insider | A — Grant or award | 6.2K | $0.00 | — | SEC | |
| Redfield Robert | Chief Medical Officer | A — Grant or award | 16.4K | $0.00 | — | SEC | |
| STOVER JACK E | Insider | A — Grant or award | 6.2K | $0.00 | — | SEC | |
| Dukes Iain D. | Chief Executive Officer | A — Grant or award | 36.9K | $0.00 | — | SEC | |
| CAUTREELS WERNER | Insider | A — Grant or award | 4.9K | $0.00 | — | SEC | |
| Shoemaker Mary Teresa | Insider | A — Grant or award | 6.2K | $0.00 | — | SEC | |
| Pauza Charles David | Chief Science Officer Virology | A — Grant or award | 18.5K | $0.00 | — | SEC | |
| Parker Charles Nolan | Chief Financial Officer | A — Grant or award | 15.4K | $0.00 | — | SEC | |
| Savchuk Nikolay | Chief Operating Officer | A — Grant or award | 16.4K | $0.00 | — | SEC | |
| TPAV, LLC | 10% Owner | J — Other acquisition / disposition | 605.5K | — | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Traws Pharma, Inc. (TRAW). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| ORBIMED ADVISORS LLC | 4 | $998K |
| Leaman John Harold | 1 | — |
| STOVER JACK E | 1 | — |
| CAUTREELS WERNER | 1 | — |
| Dukes Iain D. | 1 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in TRAW insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live TRAW dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.